Discover expanded bioanalysis solutions. Our bioanalytical experts from nonclinical and clinical will help you anticipate regulatory challenges and offer strategic solutions to guide and enable you to make informed decisions faster.
Seven global sites supporting bioanalytical programs from preclinical and clinical
900+ methods developed and 1.2M samples analyzed annually across LC-MS and immunoanalytical platforms
790+ dedicated laboratory staff members to support your small and large molecule programs
Panel discussion: new modalities within bioanalysis
Although seemingly new techniques, cell and gene therapies have been around for decades but are now becoming prevalent modalities competing with traditional methods. Our experts provide their thoughts on these new modalities, discuss the challenges associated with their implementation and review the investment into training and technologies needed to support further progression.
Overcoming hurdles for iChem workflow automation
Challenges within the pharmaceutical industry including clinical study mix, sample volumes and virtualization, unique assays, talent scarcity and rising cost pressures on lab performance, have increased the need for automation in immunochemistry. While initial automation test results confirm the benefits of sample throughput, turnaround time and laboratory staff efficiencies within immunochemistry, unanticipated method validation complexities between automated and manual processes have arisen.
Research Regulations – China NMPA
Supporting new drug application submissions using manual data will become increasingly obsolete as electronic versions can offer increased efficiency, traceability and data preservation while simultaneously providing a comprehensive audit trail for companies navigating the drug development continuum.
Quality data. Better decisions. Less time.
As you advance your molecule through the drug development continuum, you’ll need quality data to make well-informed decisions. As your partner, we work to develop the most efficient and accurate methods, removing barriers and speeding your development timeline. And, given the time pressures we all face, our high-throughput and globally transferable methods enable you to make decisions faster.
Dedicated bioanalytical services scientists armed with the latest technology.
Your drug development programs need regulatory approval to move on to the next milestone. Our scientists aren’t just familiar with the regulatory process; they are active contributors to key regulatory discussions. With leadership roles in the Global Bioanalytical Consortium, our scientists participate to help shape today’s changing regulatory environment. We have the regulatory expertise you need and will help you ask the right questions to keep your program on track. Specific knowledge of the latest bioanalytical platforms such as AB Sciex, Waters®, Hamilton Star®, Watson Plus™, Gyros™, BioPlex®, MSD and ELISA help inform your molecule’s development as we partner with you to generate high-quality results. Learn more about our Bioanalytical Services Scientists.
Learn more about our extensive bioanalysis capabilities, capacity, compliance and communication to quickly deliver quality data to move your program forward.
Central Laboratory Services integration for enhanced insights.
Providing you with key insights more quickly enables you to make informed decisions faster. When you integrate our bioanalysis services with our market-leading Central Laboratory Services, you’ll increase data delivery speed by up to 50%, reduce sample demographic discrepancies and eliminate lab-to-lab shipment fees.